Cellectar Biosciences Inc (NASDAQ:CLRB) Plunges To A New Low
[[tagnumber 0]][[tagnumber 1]]Last week, Cellectar Biosciences Inc (NASDAQ:CLRB) hit a new 52–week low shortly after announcing a secondary public offering. As a result, CLRB shares are now some 40% cheaper and, judging from yesterday‘s...